The Next New Thing

By Sarah Greene The Next New Thing Our conversation is about to get a lot more interesting. Can we invigorate science through greater interactive behavior? Way before Facebook, scientists and readers of science—pioneers by nature—were establishing their own brand of participatory media. Twenty-two years ago, when Fred Ausubel and colleagues at Massachusetts General Hospital and Harvard Medical School were formulating the lab manual Curr

| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

Way before Facebook, scientists and readers of science—pioneers by nature—were establishing their own brand of participatory media. Twenty-two years ago, when Fred Ausubel and colleagues at Massachusetts General Hospital and Harvard Medical School were formulating the lab manual Current Protocols in Molecular Biology with me, we knew its success hinged on constant correction, updating, and improvement. The publishing process had to mirror the process of experimentation. Freud’s (not Fred’s) dictum, “from error to error, one discovers the truth” was our mantra, and we recognized that traditional print media could not accommodate the accelerating pace of change in methodologies. In those pre–World Wide Web days, we developed quarterly protocol updates, with our own web of reader feedback: postage-paid response cards tucked into every supplement, encouraging researchers to send in corrections and ideas for improvement.

Dry Out, Put Away

Pharma on Facebook?

The Future of Public Engagement

What would induce the busy ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

  • Sarah Greene

    This person does not yet have a bio.

Published In

Share
May digest 2025 cover
May 2025, Issue 1

Study Confirms Safety of Genetically Modified T Cells

A long-term study of nearly 800 patients demonstrated a strong safety profile for T cells engineered with viral vectors.

View this Issue
iStock

TaqMan Probe & Assays: Unveil What's Possible Together

Thermo Fisher Logo
Meet Aunty and Tackle Protein Stability Questions in Research and Development

Meet Aunty and Tackle Protein Stability Questions in Research and Development

Unchained Labs
Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Bio-Rad
How technology makes PCR instruments easier to use.

Making Real-Time PCR More Straightforward

Thermo Fisher Logo

Products

The Scientist Placeholder Image

Biotium Launches New Phalloidin Conjugates with Extended F-actin Staining Stability for Greater Imaging Flexibility

Leica Microsystems Logo

Latest AI software simplifies image analysis and speeds up insights for scientists

BioSkryb Genomics Logo

BioSkryb Genomics and Tecan introduce a single-cell multiomics workflow for sequencing-ready libraries in under ten hours

iStock

Agilent BioTek Cytation C10 Confocal Imaging Reader

agilent technologies logo